(), abbreviated OPC, is a

pharmaceutical company The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate sympt ...

headquartered in

Tokyo Tokyo (; ja, 東京, , ), officially the Tokyo Metropolis ( ja, 東京都, label=none, ), is the capital and largest city of Japan. Formerly known as Edo, its metropolitan area () is the most populous in the world, with an estimated 37.46 ...

Osaka is a designated city in the Kansai region of Honshu in Japan. It is the capital of and most populous city in Osaka Prefecture, and the third most populous city in Japan, following Special wards of Tokyo and Yokohama. With a population of ...

and

Naruto ''Naruto'' is a Japanese manga series written and illustrated by Masashi Kishimoto. It tells the story of Naruto Uzumaki, a young ninja who seeks recognition from his peers and dreams of becoming the Hokage, the leader of his village. T ...

Japan Japan ( ja, 日本, or , and formally , ''Nihonkoku'') is an island country in East Asia. It is situated in the northwest Pacific Ocean, and is bordered on the west by the Sea of Japan, while extending from the Sea of Okhotsk in the n ...

. The company was established August 10, 1964.

History

OPC's parent company Otsuka Holdings Co. Ltd. joined the

Tokyo Stock Exchange The , abbreviated as Tosho () or TSE/TYO, is a stock exchange located in Tokyo, Japan. It is the third largest stock exchange in the world by aggregate market capitalization of its listed companies, and the largest in Asia. It had 2,292 listed ...

through an

initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investme ...

(IPO) on December 15, 2010, at which time Otsuka Holdings was Japan's No.2 drug maker by sales after industry leader

Takeda Pharmaceutical Company The is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 followin ...

. The IPO debuted at $2.4 billion, making it the largest for a pharmaceutical company up to that time.

Otsuka Pharmaceutical Co. LTD Holdings

In 1955, the company started a

football Football is a family of team sports that involve, to varying degrees, kicking a ball to score a goal. Unqualified, the word ''football'' normally means the form of football that is the most popular where the word is used. Sports commonly ...

club called "Otsuka Pharmaceutical SC." In 2005 the name changed to

Tokushima Vortis is a Japanese professional football club, currently playing in the J2 League. The team is located in Tokushima, Tokushima Prefecture. Their home stadium is Naruto Otsuka Sports Park Pocari Sweat Stadium, in Naruto, Tokushima. The name, "Vorti ...

. The club is based in Naruto. In 2008, Otsuka Pharmaceutical Co. acquired 49% of Alma S.A., which is the parent company of

CG Roxane Crystal Geyser Water Company, or just Crystal Geyser, is a private company founded in 1977 in Calistoga, California. They produce bottled sparkling water based on mineral water and spring water sources at their original facility in Calistoga. ...

. In March 2017, the company agreed to acquire Neurovance, Inc. for $250 million, gaining the firm’s Phase III-ready

ADHD Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by excessive amounts of inattention, hyperactivity, and impulsivity that are pervasive, impairing in multiple contexts, and otherwise age-inap ...

drug centanafadine (previously EB-1020). Otsuka's subsidiary Otsuka America will pay $100 million upfront for Neurovance, plus up-to $150 million in development and approval milestones. As a result of the transaction, Neurovance will operate as an indirect, wholly owned subsidiary. In July 2017, they bought

Daiya Daiya Foods Inc. is a Canada-based dairy- alternative food company located in Burnaby, British Columbia. The company was established in 2008 by Andre Kroecher and Greg Blake. Daiya's original (and likely its best known) products are cheese analogu ...

In July 2018, Otsuka agreed to acquire Visterra for $430 million cash.

Products

CalorieMate CalorieMate (カロリーメイト ''karorīmeito'') is a brand of nutritional energy bar and energy gel foods produced by Otsuka Pharmaceutical Co., in Japan. It was first released in 1983 debuting with a cheese flavored block. CalorieMate come ...

* Pocari Sweat *

Oronamin C , produced by Otsuka Chemical Holdings Co., Ltd., (distributed and sold by Otsuka Pharmaceutical Co.) is a carbonated beverage available in Japan. It is commonly called Oronamin C or Oronamin. Its name is similar to the Takeda Pharmaceutical Co. ...

* Aripiprazole / Abilify

Otsuka Holdings Co. Ltd. Holdings

In 1986, Otsuka Holdings Co. Ltd. acquired

Ridge Vineyards Ridge Vineyards is a California winery specializing in Cabernet Sauvignon, Zinfandel, and Chardonnay wines. Ridge produces wine at two winery locations in northern California. The original winery facilities are located at an elevation of on Mo ...

. In 1990, Otsuka Holdings Co. Ltd. acquired

Crystal Geyser Water Company Crystal Geyser Water Company, or just Crystal Geyser, is a private company founded in 1977 in Calistoga, California. They produce bottled sparkling water based on mineral water and spring water sources at their original facility in Calistoga. ...

. In early 2012, Otsuka announced it would focus its "future operations on CNS disorders and oncology". This decision necessitated a revision in the terms of an agreement with UCB to end collaboration on immunology products while continuing collaboration in the CNS area. In September 2013, Otsuka Holdings it acquired

Astex Pharmaceuticals Astex Pharmaceuticals ("Astex") is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and ...

for close to $900 million. In December 2014, Otsuka Holdings struck a deal to buy Avanir Pharmaceuticals for $3.54 billion. In July 2018, Otsuka Holdings acquired renal-focused ReCor Medical, Inc.

References

External links

Otsuka Pharmaceutical Company, Limited.
*(in English
Otsuka Integrated Report 2017
{{Authority control Companies listed on the Tokyo Stock Exchange Pharmaceutical companies of Japan Food and drink companies of Japan Pharmaceutical companies established in 1964 Manufacturing companies based in Tokyo Japanese brands 2010 initial public offerings Multinational companies headquartered in Japan